Cardiogen 20 mg

Cardiogen is a short peptide bioregulator developed within the Khavinson school of peptide research at the Saint Petersburg Institute of Bioregulation and Gerontology. Classified as a synthetic tripeptide with the sequence Ala-Glu-Asp (AED), Cardiogen was developed to investigate how minimal peptide sequences interact with cardiac tissue and cardiovascular research models. Its compact structure positions Cardiogen as a useful research compound for studying tissue-specific peptide signaling in laboratory contexts.

At the cellular and molecular level, Cardiogen is studied for its proposed ability to engage with chromatin structure and modulate transcriptional activity within cardiomyocyte and cardiac fibroblast cell models. Research observations within the Khavinson framework suggest that short bioregulator peptides interact with specific DNA regions to influence the expression of genes associated with cardiomyocyte maintenance, extracellular matrix synthesis, and cardiac-tissue stress adaptation. These observations are consistent with the broader proposition that short peptides act as gene-expression regulators within tissues from which their parent peptide complexes were originally extracted.

Research interest in Cardiogen centers on cardiac-tissue gene expression studies, cardiomyocyte research models, and cardiovascular fibroblast investigations. Comparative work on tissue-specific bioregulators positions Cardiogen alongside other cardiac-targeted oligopeptides used to explore peptidergic regulation of cardiovascular biology in cell-culture and animal research models (Khavinson V.K., Anisimov V.N., 2009, Advances in Gerontology). Additional reports within the Khavinson tradition describe how the AED sequence influences gene-expression activation in cardiac research models, supporting continued laboratory investigation of Cardiogen in cardiac and cardiovascular biology research.

The peptide is supplied as a lyophilized powder to ensure optimal stability during storage and handling.

See also: Cartalax 20 mg, Cortagen 20 mg, and Pancragen 20 mg.

Specifications

• Purity: 99%
• Quantity: 20 mg
• Molecular Formula: C₁₈H₃₁N₇O₉
• Molecular Weight: ~489.5 g/mol